Skip to content
Boost Up Blog – Lifestyle
Author:
MOBIA Technology Innovations
Biodexa announces major milestone for its Serenta registrational Phase 3 trial in FAP
August 20, 2026
Biodexa Initiates Support Activities for FAP Patients and Treatment Centers in France
July 29, 2026
Approval from Health Canada to expand Serenta Registrational Phase 3 trial in FAP and Update on Serenta Progress
June 29, 2026
MOBIA Retains its Canada’s Best Managed Company Gold Status
May 21, 2026